financetom
Business
financetom
/
Business
/
Ingevity Explores Strategic Alternatives for Performance Chemicals Industrial Specialties Line
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ingevity Explores Strategic Alternatives for Performance Chemicals Industrial Specialties Line
Jan 16, 2025 5:03 AM

07:38 AM EST, 01/16/2025 (MT Newswires) -- Ingevity ( NGVT ) said Thursday it is exploring strategic alternatives for its Performance Chemicals Industrial Specialties product line, including a potential divestiture of parts of its North Charleston, South Carolina, site.

The move affects pine chemical-based products used in markets such as paper, rubber, adhesives, and lubricants, but excludes the Performance Chemicals Road Technologies line and certain lignin-based products.

Ingevity ( NGVT ) also reported preliminary fiscal year 2024 results, with expected net sales of $1.4 billion, adjusted EBITDA of $360 million, and free cash flow exceeding $40 million. The company anticipates delivering adjusted EBITDA above $400 million in 2025.

Analysts polled by Capital IQ expected $1.42 billion of sales and EBITDA of $356.5 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enovix Shares Are Trading Lower Thursday: What's Going On?
Enovix Shares Are Trading Lower Thursday: What's Going On?
Sep 11, 2025
Enovix Corporation ( ENVX ) shares are trading lower Thursday after the company announced a $300 million convertible notes offering. What To Know:Enovix ( ENVX ) priced $300 million aggregate principal amount of 4.75% convertible senior notes due 2030 in a private placement to qualified institutional buyers. The company also granted purchasers an option to buy up to an additional...
LB Pharmaceuticals shares rise nearly 27% giving biotech valuation of about $382 million
LB Pharmaceuticals shares rise nearly 27% giving biotech valuation of about $382 million
Sep 11, 2025
Sept 11 (Reuters) - LB Pharmaceuticals' shares rose 27% in their Nasdaq debut on Thursday, giving the biotech firm a valuation of $381.9 million and opening the door for similarly hopeful companies as the IPO fall market heats up. ...
Ferragamo CFO La Tour resigns, La Morgia takes interim role
Ferragamo CFO La Tour resigns, La Morgia takes interim role
Sep 11, 2025
MILAN (Reuters) -Ferragamo's Chief Financial Officer Pierre La Tour is leaving the company as of September 26, after one and a half years in the role, to pursue new professional opportunities, the Italian luxury group said on Thursday. Paolo La Morgia, currently planning and control director, will be the new CFO on an interim basis, it added. Ferragamo has been...
Bionano Genomics Plans $9 Million Public Offering
Bionano Genomics Plans $9 Million Public Offering
Sep 11, 2025
12:20 PM EDT, 09/11/2025 (MT Newswires) -- Bionano Genomics ( BNGO ) on Thursday disclosed a combined public offering of shares and accompanying warrants to raise an expected $9 million in proceeds. The company will issue up to 2 million shares of common stock, together with Series E and Series F warrants, at an assumed combined price of $4.92 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved